Please assess the completion status of the following clinical trial:

Trial Title: Safety of Lumiracoxib in Patients With Osteoarthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \>=50 years old~* Primary osteoarthritis in hip, hand, knee or spine for at least 3 month~* Pain in the target joint of moderate intensity~* Written informed consent~Exclusion Criteria:~* Secondary osteoarthritis~* Active upper gastro intestinal tract ulceration~* Inflammatory joint disease~* Gout~* Clinically significant hepatic or renal disease~Other in and exclusion criteria may apply

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).